The offer to subscribe for shares in Idogen AB (publ) according to the terms set out in the prospectus is not directed to people whose participation in the offer would require additional prospectuses, registration measures or other measures other than those pursuant to Swedish law. The prospectus and other documents connected to the prospectus may not be distributed in any country in which the distribution or the offer requires additional measures as outlined above or are contrary to the regulations in such countries. The subscription rights, paid subscription shares (BTA) and shares have not been registered and will not be registered in accordance with the United States Securities Act from 1933 in its current wording or any provincial legislation in Australia, Japan, New Zealand, Singapore, South Africa, Hong Kong or Canada, and may not be offered or sold, directly or indirectly, to persons domiciled in any of these countries or for the account of such a person. Application for subscription of shares contrary to the above may be viewed as invalid and consequently ignored.
Disputes arising from the offer, the contents of the prospectus and thereto connected legal matters shall be determined exclusively by a Swedish Court. Swedish law is exclusively applicable on the prospectus and the offer according to the prospectus.
In order to be eligible to view the information on the following web page, you shall be deemed, by accessing the following web page, to have confirmed and represented that (i) you have read and accepted the terms and restrictions set out above, and (ii) you are not located in the United States of America, Australia, Japan, New Zealand, Singapore, South Africa, Hong Kong or Canada.